About Obagi Medical Products (NASDAQ:OMPI)
Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:OMPI
CUSIPN/A
Phone+1-562-6281007
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions
What is Obagi Medical Products' stock symbol?
Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI."
Has Obagi Medical Products been receiving favorable news coverage?
Media coverage about OMPI stock has trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Obagi Medical Products earned a daily sentiment score of 0.20 on Accern's scale. They also assigned news articles about the specialty pharmaceutical company an impact score of 47.26 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
How do I buy shares of Obagi Medical Products?
Shares of OMPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Obagi Medical Products?
Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007.
MarketBeat Community Rating for Obagi Medical Products (OMPI)
MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe OMPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Obagi Medical Products (NASDAQ:OMPI) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 4/24/2016 forward)
Obagi Medical Products (NASDAQ:OMPI) Earnings History and Estimates Chart
Obagi Medical Products (NASDAQ OMPI) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 3/14/2013 | Q4 2012 | $0.21 | $0.15 | $30.06 million | $30.30 million | View | Listen |  |
| 11/1/2012 | Q312 | $0.20 | $0.22 | $28.87 million | $29.10 million | View | N/A | |
| 8/2/2012 | | $0.20 | $0.22 | | | View | N/A | |
| 5/3/2012 | | $0.21 | $0.16 | | | View | N/A | |
| 3/8/2012 | | $0.19 | $0.27 | | | View | N/A | |
| 11/9/2011 | | $0.17 | $0.24 | | | View | N/A | |
| 8/4/2011 | | $0.16 | $0.18 | | | View | N/A | |
| 5/5/2011 | | $0.13 | $0.16 | | | View | N/A | |
| 3/10/2011 | | $0.09 | $0.14 | | | View | N/A | |
| 11/4/2010 | Q3 2010 | $0.10 | $0.15 | | | View | N/A | |
| 8/5/2010 | Q2 2010 | $0.17 | $0.20 | | | View | N/A | |
| 5/6/2010 | Q1 2010 | $0.09 | $0.09 | | | View | N/A | |
| 3/11/2010 | Q4 2009 | $0.17 | $0.22 | | | View | N/A | |
| 11/5/2009 | Q3 2009 | $0.14 | $0.14 | | | View | N/A | |
| 8/6/2009 | Q2 2009 | $0.12 | $0.15 | | | View | N/A | |
| 5/7/2009 | Q1 2009 | $0.08 | $0.08 | | | View | N/A | |
| 3/5/2009 | Q4 2008 | $0.13 | $0.13 | | | View | N/A | |
| 11/6/2008 | Q3 2008 | $0.14 | $0.13 | | | View | N/A | |
| 8/11/2008 | Q2 2008 | $0.19 | $0.20 | | | View | N/A | |
| 5/5/2008 | Q1 2008 | $0.18 | $0.13 | | | View | N/A | |
| 3/3/2008 | Q4 2007 | $0.26 | $0.21 | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Obagi Medical Products (NASDAQ:OMPI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Obagi Medical Products (NASDAQ OMPI) Insider Trading and Institutional Ownership History
Obagi Medical Products (NASDAQ OMPI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Obagi Medical Products (NASDAQ OMPI) News Headlines
| Source: |
|
No headlines for this company have been tracked by MarketBeat.com
Obagi Medical Products (NASDAQ:OMPI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Obagi Medical Products (NASDAQ:OMPI) Income Statement, Balance Sheet and Cash Flow Statement
Obagi Medical Products (NASDAQ OMPI) Stock Chart for Tuesday, April, 24, 2018
Loading chart…
